Through interleukin-6 (IL-6), TGF-β, and interleukin-21 (IL-21), the TME stomach myofibroblasts stimulate Th17 differentiation, which by secretion of IL-17 will promote tumor progression [58,59]. The gene discussed is TGFB1; the disease is neoplasm.